|
1
|
Rawla P and Barsouk A: Epidemiology of
gastric cancer: Global trends, risk factors and prevention. Prz
Gastroenterol. 14:26–38. 2019.PubMed/NCBI
|
|
2
|
Giovannucci E, Harlan DM, Archer MC,
Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG and
Yee D: Diabetes and cancer: A consensus report. Diabetes Care.
33:1674–1685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saarela K, Tuomilehto J, Sund R, Keskimäki
I, Hartikainen S and Pukkala E: Cancer incidence among Finnish
people with type 2 diabetes during 1989–2014. Eur J Epidemiol.
34:259–265. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abudawood M: Diabetes and cancer: A
comprehensive review. J Res Med Sci. 24:942019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gorgisen G, Gulacar IM and Ozes ON: The
role of insulin receptor substrate (IRS) proteins in oncogenic
transformation. Cell Mol Biol (Noisy-le-grand). 63:1–5. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shaw LM: The insulin receptor substrate
(IRS) proteins: At the intersection of metabolism and cancer. Cell
Cycle. 10:1750–1756. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gibson SL, Ma Z and Shaw LM: Divergent
roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle.
6:631–637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mardilovich K, Pankratz SL and Shaw LM:
Expression and function of the insulin receptor substrate proteins
in cancer. Cell Commun Signal. 7:142009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gorgisen G, Hapil FZ, Yilmaz O, Cetin Z,
Pehlivanoglu S, Ozbudak IH, Erdogan A and Ozes ON: Identification
of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor
samples of non-small cell lung cancer (NSCLC): Implications for
aberrant insulin signaling in development of cancer. Genet Mol Bio.
42:15–25. 2019. View Article : Google Scholar
|
|
10
|
Lin MW, Huang MF and Wu MH: Association of
Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp
variant of insulin receptor subtrate-2 with polycystic ovary
syndrome in the Chinese population. J Ovarian Res. 7:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gelaleti RB, Damasceno DC, Salvadori DM,
Marcondes JP, Lima PH, Morceli G, Calderon IM and Rudge MV: IRS-1
gene polymorphism and DNA damage in pregnant women with diabetes or
mild gestational hyperglycemia. Diabetol Metab Syndr. 7:302015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Wang A, Ma H and Xu Y:
Association between insulin receptor substrate 1 Gly972Arg
polymorphism and cancer risk. Tumour Biol. 34:2929–2936. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ayaz L, Karakaş Çelik S and Cayan F: The
G1057D polymorphism of insulin receptor substrate-2 associated with
gestational diabetes mellitus. Gynecol Endocrinol. 30:165–168.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Christopoulos P, Mastorakos G, Gazouli M,
Deligeoroglou E, Katsikis I, Diamanti-Kandarakis E, Panidis D and
Creatsas G: Study of association of IRS-1 and IRS-2 genes
polymorphisms with clinical and metabolic features in women with
polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol.
26:698–703. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carvalheira JB, Ribeiro EB, Folli F,
Velloso LA and Saad MJ: Interaction between leptin and insulin
signaling pathways differentially affects JAK-STAT and PI
3-kinase-mediated signaling in rat liver. Biol Chem. 384:151–159.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
D'Alfonso R, Marini MA, Frittitta L, Sorge
R, Frontoni S, Porzio O, Mariani LM, Lauro D, Gambardella S,
Trischitta V, et al: Polymorphisms of the insulin receptor
substrate-2 in patients with type 2 diabetes. J Clin Endocrinol
Metab. 88:317–322. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arikoglu H, Aksoy Hepdogru M, Erkoc Kaya
D, Asik A, Ipekci SH and Iscioglu F: IRS1 gene polymorphisms
Gly972Arg and Ala513Pro are not associated with insulin resistance
and type 2 diabetes risk in non-obese Turkish population. Meta
Gene. 2:579–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brancati FL, Kao WL, Folsom AR, Watson RL
and Szklo M: Incident type 2 diabetes mellitus in African American
and white adults: The atherosclerosis risk in communities study.
JAMA. 283:2253–2259. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thameem F, Puppala S, Schneider J,
Bhandari B, Arya R, Arar NH, Vasylyeva TL, Farook VS, Fowler S,
Almasy L, et al: The Gly(972)Arg variant of human IRS1 gene is
associated with variation in glomerular filtration rate likely
through impaired insulin receptor signaling. Diabetes.
61:2385–2393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Wang L, Liu L, Jiang H, Ma C and Hao
T: Association between IRS-1 Gly972Arg polymorphism and colorectal
cancer risk. Tumour Biol. 35:6581–6585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fall K, Stark JR, Mucci LA, Chan J,
Stampfer MJ, Kurth T, Febbo PG, Kantoff P and Ma J: No association
between a polymorphic variant of the IRS-1 gene and prostate cancer
risk. Prostate. 68:1416–1420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neuhausen SL, Slattery ML, Garner CP, Ding
YC, Hoffman M and Brothman AR: Prostate cancer risk and IRS1, IRS2,
IGF1, and INS polymorphisms: Strong association of IRS1 G972R
variant and cancer risk. Prostate. 64:168–174. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cayan F, Tok E, Aras-Ateş N, Ayaz L, Akbay
E, Gen R, Karakaş S and Dilek S: Insulin receptor substrate 2 gene
polymorphism: Is it associated with endometrial cancer? Gynecol
Endocrinol. 26:378–382. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Çayan F, Dilek S, Ramazan G, Akbay E,
Aras-Ateş N and Ayaz L: Association of insulin receptor substrate-2
gene polymorphism with ovarian cancer. Balkan Med J. 28:14–17.
2011.
|
|
25
|
Yukseloglu EH, Celik SK, Kucuk MU, Yalin
E, Ozkal SS, Ates C, Berkoz M, Yalin S and Ates NA: IRS-2 G1057D
polymorphism in Turkish patients with colorectal cancer. Prz
Gastroenterol. 9:88–92. 2014.PubMed/NCBI
|
|
26
|
Yin J, Zhang Z, Zheng H and Xu L: IRS-2
rs1805097 polymorphism is associated with the decreased risk of
colorectal cancer. Oncotarget. 8:25107–25114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu Y, Zhou M, Zhang K, Kong X, Hu X, Li K
and Liu L: Lack of association between insulin receptor substrate2
rs1805097 polymorphism and the risk of colorectal and breast
cancer: A meta-analysis. PLoS One. 9:e869112014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ijaz A, Babar S, Sarwar S, Shahid SU and
Shabana: The combined role of allelic variants of IRS-1 and IRS-2
genes in susceptibility to type 2 diabetes in the Punjabi Pakistani
subjects. Diabetol Metab Syndr. 11:642019. View Article : Google Scholar : PubMed/NCBI
|
